Cormedix Earnings Preview
Portfolio Pulse from Benzinga Insights
Cormedix (NASDAQ:CRMD) is scheduled to release its quarterly earnings report on March 12, 2024, with analysts expecting an EPS of $-0.20. Historical data shows that the company's stock price reacts more significantly to guidance than to earnings beats or misses. Last quarter, Cormedix beat the EPS estimate, resulting in a 6.39% increase in its share price. Over the past year, CRMD shares have decreased by 6.13%, indicating potential concern among long-term investors ahead of the earnings announcement.
March 11, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cormedix is expected to report an EPS of $-0.20 for the upcoming quarter. Historical performance indicates potential stock price movement based on the earnings outcome and future guidance.
Given the historical sensitivity of CRMD's stock price to earnings announcements and guidance, the upcoming report could lead to significant short-term price movement. However, the direction is uncertain, as it depends on whether the company beats the EPS estimate and the nature of the future guidance provided. The mixed historical stock performance post-earnings and the overall negative trend over the past year add complexity to predicting the immediate impact.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100